Welcome to our dedicated page for Earth Science Te SEC filings (Ticker: ETST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Earth Science Tech, Inc. filings document formal public-company disclosures for a Florida issuer with common stock quoted over the counter. The record includes Form 8-K reports covering Regulation FD releases, financial-result announcements, the launch of MyOnlineConsultation.com through MOCTeledoc, and the company’s SIC 2834 pharmaceutical classification.
Other filings disclose governance and capital-structure matters, including bylaw amendments for electronic shareholder notices, officer and director compensation arrangements, auditor changes, investor-relations engagement, and the registered class of ETST common stock. These documents tie the company’s healthcare portfolio disclosures to its reporting controls, board practices and OTC security status.
Earth Science Tech, Inc. Schedule 13G filing: Giorgio R. Saumat reports beneficial ownership of 123,737,006 shares of Common Stock, representing 42.94% of the class as of 06/22/2026. The filing states Mr. Saumat has sole voting and sole dispositive power over these shares.
Earth Science Tech, Inc. reported full-year results for the fiscal year ended March 31, 2026, showing higher revenue and earnings while reducing debt. Revenue increased to $35,695,614 from $33,117,624, and net income rose to $3,600,937 from $3,253,635, with earnings per share improving to $0.012.
The company ended the year with total assets of $8,969,337 and total liabilities of $1,928,573, resulting in total equity of $7,040,764. Management highlighted positive operating cash flow, a stronger balance sheet without adding new debt, and share repurchases and retirements of more than 7.1 million common shares in fiscal 2026, plus over 3.1 million additional shares bought in fiscal Q1 2027.
Earth Science Tech, Inc. reports another profitable year, growing revenue to $35.7 million and net income to $3.6 million for the year ended March 31, 2026. The health and wellness holding company, built around compounding pharmacies, telemedicine and a small consumer brand, generated a 71% gross margin.
Operating expenses rose 6% as marketing more than tripled to support growth, while salaries and general and administrative costs declined. Cash from operations was $1.9 million, funding $1.9 million of investment and $0.7 million of financing outflows, including stock repurchases.
Total liabilities fell to $1.9 million and long‑term debt was eliminated, helping boost total equity to $7.0 million. The company repurchased and cancelled shares, and states it has not issued equity since early 2023, emphasizing non‑dilutive financing and an authorized $10 million share repurchase program.
Earth Science Tech, Inc. provided a shareholder update highlighting major milestones for the fiscal year ended March 31, 2026. The company reports repurchasing over 6.9 million shares of common stock since fiscal Q1 2026 and states it has been cash flow positive across its operating platform while pursuing debt-free growth.
The Health/Wellness segment is described as the core operating engine expected to generate most revenue, with Peaks Curative surpassing $2 million in revenue in the first week of fiscal Q4 2026. Management also notes three additional properties under development awaiting final permits and says 3,150,392 shares of common stock have been retired quarter-to-date, positioning the company, in its view, in real financial strength entering the new fiscal year.
Earth Science Tech, Inc. reported that its Board of Directors amended Article I, Section 4 of its Bylaws, effective April 16, 2026. The change permits delivery of shareholder meeting notices by electronic transmission, including email, to modernize corporate governance, improve administrative efficiency, and reduce printing and mailing costs. The amended bylaw language is set out in a Board Resolution filed as Exhibit 3.1 to this report.
Earth Science Tech, Inc. reports the launch of MyOnlineConsultation.com through its MOCTeledoc, LLC division, completing what it describes as a fully vertically integrated telehealth and pharmacy ecosystem. MOCTeledoc is introduced as a doctor network that provides both technology and clinical staffing to digital health companies.
The company states that MOCTeledoc was cash-flow-positive during its beta phase and is expected to be immediately accretive to earnings as it is rolled out nationwide. Management highlights that offering the custom telehealth platform and prescriber network as a turnkey service creates a new revenue stream and a funnel to Earth Science Tech’s in-house compounding pharmacies.
The filing also reiterates that Earth Science Tech is a diversified health and wellness holding company operating compounding pharmacies, telemedicine platforms, targeted healthcare facilities, a real estate and asset management arm, a consumer products brand, and a non-profit foundation supporting patient prescription costs.
Earth Science Tech, Inc. reported that on March 11, 2026 it mutually agreed to renew the employment agreements of Chief Financial Officer Ernesto L. Flores and Chief Technology Officer Christopher A. Rose for an additional one-year term.
The original agreements were entered into on March 11, 2025, and all other material terms and conditions remain unchanged and in full force and effect.
Earth Science Tech, Inc. reported a change in its independent auditor. On February 17, 2026, Stephano Slack LLC resigned as the company’s independent registered public accounting firm. Its prior audit reports for the year ended March 31, 2025 contained no adverse opinions, disclaimers, or qualifications.
The company states there were no disagreements or reportable events with Stephano Slack under SEC Regulation S-K during the referenced periods. Also on February 17, 2026, Earth Science Tech engaged Semple, Marchal & Cooper, LLP as its new independent PCAOB auditor for the fiscal year ending March 31, 2026 and issued a press release describing this engagement.
Earth Science Tech, Inc. reported a strong third fiscal quarter 2026 with revenue of $8.4 million, up 14.1% year-over-year, and gross margin expanding to 76.3% from 69.2%. Net income jumped to $910,000 from $206,000, while Adjusted EBITDA rose to $1.2 million from $0.3 million.
The Company highlighted improving balance sheet quality, with total assets of $8.1 million, working capital of $773,000, no bank debt, and 3.7 million shares repurchased and retired over nine months. Multiple operating units are generating positive cash flow, and Peaks, its telemedicine platform, surpassed $2.0 million in revenue in under a year.
Management and the Board announced governance and cost initiatives expected to deliver approximately $1.4 million in annualized savings, supporting an increase in net income from about $3.3 million in fiscal 2025 to a projected $4.7 million in fiscal 2026. Actions include voiding CEO and COO employment contracts, waiving variable pay in the interim, reducing Board meeting fees to $2,000, planning a non-binding say-on-pay vote, evaluating retirement of Series B preferred stock, and targeting divestiture of non-core assets.
Earth Science Tech, Inc. reported a strong third fiscal quarter 2026 with revenue of $8.4 million, up 14.1% year-over-year, and gross margin expanding to 76.3% from 69.2%. Net income jumped to $910,000 from $206,000, while Adjusted EBITDA rose to $1.2 million from $0.3 million.
The Company highlighted improving balance sheet quality, with total assets of $8.1 million, working capital of $773,000, no bank debt, and 3.7 million shares repurchased and retired over nine months. Multiple operating units are generating positive cash flow, and Peaks, its telemedicine platform, surpassed $2.0 million in revenue in under a year.
Management and the Board announced governance and cost initiatives expected to deliver approximately $1.4 million in annualized savings, supporting an increase in net income from about $3.3 million in fiscal 2025 to a projected $4.7 million in fiscal 2026. Actions include voiding CEO and COO employment contracts, waiving variable pay in the interim, reducing Board meeting fees to $2,000, planning a non-binding say-on-pay vote, evaluating retirement of Series B preferred stock, and targeting divestiture of non-core assets.
Earth Science Tech, Inc. reported a strong third fiscal quarter 2026 with revenue of $8.4 million, up 14.1% year-over-year, and gross margin expanding to 76.3% from 69.2%. Net income jumped to $910,000 from $206,000, while Adjusted EBITDA rose to $1.2 million from $0.3 million.
The Company highlighted improving balance sheet quality, with total assets of $8.1 million, working capital of $773,000, no bank debt, and 3.7 million shares repurchased and retired over nine months. Multiple operating units are generating positive cash flow, and Peaks, its telemedicine platform, surpassed $2.0 million in revenue in under a year.
Management and the Board announced governance and cost initiatives expected to deliver approximately $1.4 million in annualized savings, supporting an increase in net income from about $3.3 million in fiscal 2025 to a projected $4.7 million in fiscal 2026. Actions include voiding CEO and COO employment contracts, waiving variable pay in the interim, reducing Board meeting fees to $2,000, planning a non-binding say-on-pay vote, evaluating retirement of Series B preferred stock, and targeting divestiture of non-core assets.
Earth Science Tech, Inc. reported stronger results for the quarter ended December 31, 2025. Revenue for the quarter rose to $8.39 million from $7.35 million, lifting gross profit to $6.40 million and expanding gross margin to 76% from 69%. Net income for the quarter increased to $0.91 million from $0.21 million, while nine-month net income grew to $2.31 million from $2.08 million on revenue of $26.20 million versus $24.44 million. Total assets reached $8.09 million with liabilities of $2.29 million and stockholders’ equity of $5.80 million. Operating cash flow was $1.06 million for the nine months, with cash declining to $0.42 million after investment spending and share repurchases. The company continued building its healthcare and telemedicine platform through the acquisitions of Las Villas Health, DOConsultations, and 80% of Magnefuse, and repurchased about 3.7 million shares for $0.65 million.